Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
Holding ERNA?
Track your performance easily

Eterna Therapeutics (ERNA) Financial Statements

213 Followers

Eterna Therapeutics Financial Overview

Eterna Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.424; its P/E ratio is -0.30; Eterna Therapeutics is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $-2.40. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 47.00K$ 47.00K$ -4.00K$ 51.00K$ 21.00K
Gross Profit$ -48.00K$ -14.00K$ -141.00K$ -69.00K$ 21.00K
EBIT$ -5.50M$ -6.17M$ -5.62M$ -5.60M$ -4.50M
EBITDA$ -4.45M$ -5.18M$ -4.88M$ -5.03M-
Net Income Common Stockholders$ -5.54M$ -6.60M$ -6.18M$ -5.59M$ -4.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.60M$ 5.12M$ 7.58M$ 4.55M$ 1.84M
Total Assets$ 46.49M$ 49.66M$ 49.13M$ 52.25M$ 46.95M
Total Debt$ 49.20M$ 47.45M$ 41.84M$ 39.60M$ 35.14M
Net Debt$ 46.60M$ 42.34M$ 34.27M$ 35.05M$ 33.30M
Total Liabilities$ 55.01M$ 53.07M$ 46.90M$ 48.69M$ 43.09M
Stockholders Equity$ -8.53M$ -3.41M$ 2.23M$ 3.56M$ 3.87M
Cash Flow-
Free Cash Flow$ -2.55M$ -3.80M$ -4.72M$ -5.80M-
Operating Cash Flow$ -2.30M$ -3.70M$ -4.70M$ -5.80M$ -3.90M
Investing Cash Flow$ -249.00K$ -97.00K$ -19.00K--
Financing Cash Flow$ -22.00K$ 1.39M$ 7.70M$ 8.54M$ 312.00K
Currency in USD

Eterna Therapeutics Earnings and Revenue History

Eterna Therapeutics Debt to Assets

Eterna Therapeutics Cash Flow

Eterna Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis